AstraZeneca, Pfizer, Gilead release cancer drug data
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Tag: Pfizer
Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival
Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move…
Pfizer Licenses 3SBio Cancer Drug for Record $1.2 Billion
Pfizer will pay $1.25 billion upfront to license an experimental cancer drug out of China, in a deal that underscores…